海外上市

Switzerland/China IPOs: brand, not depth is the lure of ‘new New York’

Alpine nation has relaxed audit requirements and a reputation for financial sophistication

Switzerland is becoming the destination of choice for mainland Chinese companies seeking a foreign listing. Drugmaker Joincare Pharmaceutical Group is the latest to announce plans to float on the Swiss stock exchange.

Beijing hopes the alpine nation will be the new New York for companies seeking foreign funding. It may be disappointed

The SIX Swiss Exchange has recently been the choice for businesses including equipment maker Sany Heavy Industry, pharma group Lepu Medical and two electric car battery manufacturers, Gotion High-Tech and Ningbo Shanshan.

您已阅读25%(556字),剩余75%(1697字)包含更多重要信息,订阅以继续探索完整内容,并享受更多专属服务。
版权声明:本文版权归manbetx20客户端下载 所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。
设置字号×
最小
较小
默认
较大
最大
分享×